Risk factor
Good trading liquidity
Profitability factor
Somewhat favourable analyst view
About
Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of medical diagnostic services within China. The company delivers comprehensive diagnostic solutions to a broad spectrum of healthcare organizations, including general and specialized hospitals, community health centers, township clinics, physical examination facilities, and disease prevention and control agencies. Supporting its extensive operations, Dian Diagnostics manages a global network of 40 advanced chain laboratories. Beyond its core diagnostic offerings, the company is also deeply involved in the research, development, and manufacturing of in vitro diagnostic reagents, along with associated equipment and consumables. Furthermore, it plays a crucial role in the medical supply chain, facilitating the provision of various products such as medical equipment, pharmaceuticals, clinical samples, biological products, finished blood products, live animals, chemical compounds, and diagnostic reagents. Dian Diagnostics also specializes in comprehensive cold chain logistics, which includes transportation, warehousing, product sales, and technical support services for temperature-sensitive medical goods. Founded in 2001, the company is headquartered in Hangzhou, China. It adopted its current name, Dian Diagnostics Group Co.,Ltd., in November 2017, having previously operated as Zhejiang DIAN Diagnostics Co., Ltd.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is overpriced on P/E, of fair value o
Target Price
The average target price of 300244.SZ is 18.1 and suggests 15.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to